Zhou EM, Tang Y, Liao C, Lin S, et al. Multi-courses of blinatumomab combined with reduced dose chemotherapy has been successfully used in chemo-intolerant middle to high-risk pediatric B-ALL patients with invasive fungal disease. Ann Hematol 2025;104:3495-3504.
PMID: 40445300